These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 31638723)
21. Efficacy and acceptability of adjunctive psychological and pharmacological interventions for treatment-resistant depression: protocol for a systematic review and network meta-analysis. Husain MI; Strawbridge R; Carter B; Jones BDM; Young A; Carvalho AF BMJ Open; 2019 May; 9(5):e028538. PubMed ID: 31092667 [TBL] [Abstract][Full Text] [Related]
22. Is treatment-resistant depression a useful concept? Malhi GS; Byrow Y Evid Based Ment Health; 2016 Feb; 19(1):1-3. PubMed ID: 26767390 [TBL] [Abstract][Full Text] [Related]
23. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database. Kubitz N; Mehra M; Potluri RC; Garg N; Cossrow N PLoS One; 2013; 8(10):e76882. PubMed ID: 24204694 [TBL] [Abstract][Full Text] [Related]
24. Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder: A Proof-of-concept Trial. Regenold WT; Noorani RJ; Piez D; Patel P Brain Stimul; 2015; 8(5):855-61. PubMed ID: 26187603 [TBL] [Abstract][Full Text] [Related]
25. Staging Treatment Intensity and Defining Resistant Depression: Historical Overview and Future Directions. Salloum NC; Papakostas GI J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31163105 [TBL] [Abstract][Full Text] [Related]
26. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression. Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453 [TBL] [Abstract][Full Text] [Related]
27. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression. Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066 [TBL] [Abstract][Full Text] [Related]
31. How different definition criteria may predict clinical outcome in treatment resistant depression: Results from a prospective real-world study. Zanardi R; Carminati M; Attanasio F; Fazio V; Maccario M; Colombo C Psychiatry Res; 2024 Apr; 334():115818. PubMed ID: 38422869 [TBL] [Abstract][Full Text] [Related]
32. Psychological aspects and psychotherapy for TRD. Hu LY Prog Brain Res; 2023; 278():169-176. PubMed ID: 37414492 [TBL] [Abstract][Full Text] [Related]
33. The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method. Peeters FP; Ruhe HG; Wichers M; Abidi L; Kaub K; van der Lande HJ; Spijker J; Huibers MJ; Schene AH J Affect Disord; 2016 Nov; 205():365-371. PubMed ID: 27568174 [TBL] [Abstract][Full Text] [Related]
34. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder. Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441 [TBL] [Abstract][Full Text] [Related]
35. One-year incidence rate of Treatment Resistant Depression (TRD) and treatment characteristics in China. Wang H; Wu T; Dong S; Guan M; Liu A; Jiang K; Chi R; Qiu H; Dong W; Si T J Affect Disord; 2022 May; 305():77-84. PubMed ID: 35240201 [TBL] [Abstract][Full Text] [Related]
36. The Individual and Societal Burden of Treatment-Resistant Depression: An Overview. Baig-Ward KM; Jha MK; Trivedi MH Psychiatr Clin North Am; 2023 Jun; 46(2):211-226. PubMed ID: 37149341 [TBL] [Abstract][Full Text] [Related]
37. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952 [TBL] [Abstract][Full Text] [Related]
38. Determinants of Treatment-Resistant Depression: The Salience of Benzodiazepines. Parker GB; Graham RK J Nerv Ment Dis; 2015 Sep; 203(9):659-63. PubMed ID: 26241407 [TBL] [Abstract][Full Text] [Related]
39. Treatment-resistant depression in primary care across Canada. Rizvi SJ; Grima E; Tan M; Rotzinger S; Lin P; Mcintyre RS; Kennedy SH Can J Psychiatry; 2014 Jul; 59(7):349-57. PubMed ID: 25007419 [TBL] [Abstract][Full Text] [Related]
40. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder. Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]